These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 21787158)

  • 1. Coenzyme Q10 and its relation with oxidant and antioxidant system markers in patients with end-stage renal disease.
    Gokbel H; Atalay H; Okudan N; Solak Y; Belviranli M; Turk S
    Ren Fail; 2011; 33(7):677-81. PubMed ID: 21787158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compositional and oxidative analysis in the saliva and serum of predialysis chronic kidney disease patients and end-stage renal failure patients on peritoneal dialysis.
    Bibi G; Green Y; Nagler RM
    Ther Apher Dial; 2008 Apr; 12(2):164-70. PubMed ID: 18387167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cu/Zn superoxide dismutase plasma levels as a new useful clinical biomarker of oxidative stress in patients with end-stage renal disease.
    Pawlak K; Pawlak D; Mysliwiec M
    Clin Biochem; 2005 Aug; 38(8):700-5. PubMed ID: 15963971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of oxidative stress in patients with chronic renal failure whose hypertension is treated with peritoneal dialysis.
    Demirci S; Sekeroğlu MR; Noyan T; Köçeroğlu R; Soyoral YU; Dülger H; Erkoç R
    Cell Biochem Funct; 2011 Apr; 29(3):249-54. PubMed ID: 21465497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase in oxidative stress but not in antioxidant capacity with advancing stages of chronic kidney disease.
    Karamouzis I; Sarafidis PA; Karamouzis M; Iliadis S; Haidich AB; Sioulis A; Triantos A; Vavatsi-Christaki N; Grekas DM
    Am J Nephrol; 2008; 28(3):397-404. PubMed ID: 18063858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythrocyte susceptibility to oxidative stress in chronic renal failure patients under different substitutive treatments.
    Lucchi L; Bergamini S; Iannone A; Perrone S; Stipo L; Olmeda F; Caruso F; Tomasi A; Albertazzi A
    Artif Organs; 2005 Jan; 29(1):67-72. PubMed ID: 15644086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coenzyme Q10 administration suppresses both oxidative and antioxidative markers in hemodialysis patients.
    Sakata T; Furuya R; Shimazu T; Odamaki M; Ohkawa S; Kumagai H
    Blood Purif; 2008; 26(4):371-8. PubMed ID: 18509244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress in chronic renal failure patients treated by peritoneal dialysis.
    Al-Hashimi AF; Mohammed FH; Al-Khazragi AS
    Saudi Med J; 2004 Sep; 25(9):1186-92. PubMed ID: 15448763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antioxidant enzymes show adaptation to oxidative stress in athletes and increased stress in hemodialysis patients.
    Knap B; Prezelj M; Buturović-Ponikvar J; Ponikvar R; Bren AF
    Ther Apher Dial; 2009 Aug; 13(4):300-5. PubMed ID: 19695063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmented antioxidant status in Tamoxifen treated postmenopausal women with breast cancer on co-administration with Coenzyme Q10, Niacin and Riboflavin.
    Yuvaraj S; Premkumar VG; Vijayasarathy K; Gangadaran SG; Sachdanandam P
    Cancer Chemother Pharmacol; 2008 May; 61(6):933-41. PubMed ID: 17668211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Free and total plasma malondialdehyde in chronic renal insufficiency and in dialysis patients.
    De Vecchi AF; Bamonti F; Novembrino C; Ippolito S; Guerra L; Lonati S; Salini S; Aman CS; Scurati-Manzoni E; Cighetti G
    Nephrol Dial Transplant; 2009 Aug; 24(8):2524-9. PubMed ID: 19264746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between interleukin-8 and the oxidant-antioxidant system in end-stage renal failure patients.
    Aydin M; Ozkok E; Ozturk O; Agachan B; Yilmaz H; Yaylim I; Kebabcioglu S; Ispir T
    Exp Clin Transplant; 2007 Jun; 5(1):610-3. PubMed ID: 17617053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutathione, glutathione-related enzymes, and total antioxidant capacity in patients on maintenance dialysis.
    Ahmadpoor P; Eftekhar E; Nourooz-Zadeh J; Servat H; Makhdoomi K; Ghafari A
    Iran J Kidney Dis; 2009 Jan; 3(1):22-7. PubMed ID: 19377255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress markers in hemodialysis and peritoneal dialysis patients, including coenzyme Q10 and ischemia-modified albumin.
    Mehmetoglu I; Yerlikaya FH; Kurban S; Erdem SS; Tonbul Z
    Int J Artif Organs; 2012 Mar; 35(3):226-32. PubMed ID: 22461118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of omega-3 fatty acid on oxidative stress in patients on hemodialysis.
    Tayyebi-Khosroshahi H; Houshyar J; Tabrizi A; Vatankhah AM; Razzagi Zonouz N; Dehghan-Hesari R
    Iran J Kidney Dis; 2010 Oct; 4(4):322-6. PubMed ID: 20852375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of hemodialysis on lipid peroxidation and antioxidant system in patients with chronic renal failure.
    Mohora M; Mircescu G; Cîrjan C; Mihăilescu I; Gîrneaţă L; Ursea N; Dinu V
    Rom J Intern Med; 1995; 33(3-4):237-42. PubMed ID: 8646196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of dialytic modalities on clinical outcomes in ESRD patients with familial Mediterranean fever.
    Sahin S; Sahin GM; Ergin H; Kantarci G
    Ren Fail; 2007; 29(3):315-9. PubMed ID: 17497446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of trimetazidine on lipid peroxidation in patients with end-stage renal disease.
    Aygen B; Celiker H; Dogukan A; Ilhan N
    Methods Find Exp Clin Pharmacol; 2008 Dec; 30(10):757-60. PubMed ID: 19271025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of intravenous iron sucrose on oxidative stress in peritoneal dialysis patients.
    Saglam F; Cavdar C; Uysal S; Cavdar Z; Camsari T
    Ren Fail; 2007; 29(7):849-54. PubMed ID: 17994454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levels of asymmetric dimethylarginine, nitric oxide and lipid peroxidation markers in patients with end-stage renal disease having peritoneal dialysis treatment.
    Göçmen AY; Sahin E; Koçak H; Tuncer M; Gümüşlü S
    Clin Biochem; 2008 Jul; 41(10-11):836-40. PubMed ID: 18457672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.